HUP0300236A3 - Use of polyunsaturated fatty acids for reducing the incidence of necrotizing enterocolitis and process for their preparation - Google Patents
Use of polyunsaturated fatty acids for reducing the incidence of necrotizing enterocolitis and process for their preparationInfo
- Publication number
- HUP0300236A3 HUP0300236A3 HU0300236A HUP0300236A HUP0300236A3 HU P0300236 A3 HUP0300236 A3 HU P0300236A3 HU 0300236 A HU0300236 A HU 0300236A HU P0300236 A HUP0300236 A HU P0300236A HU P0300236 A3 HUP0300236 A3 HU P0300236A3
- Authority
- HU
- Hungary
- Prior art keywords
- incidence
- preparation
- reducing
- fatty acids
- polyunsaturated fatty
- Prior art date
Links
- 206010051606 Necrotising colitis Diseases 0.000 title 1
- 208000004995 necrotizing enterocolitis Diseases 0.000 title 1
- 201000006195 perinatal necrotizing enterocolitis Diseases 0.000 title 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Fats And Perfumes (AREA)
- Silicates, Zeolites, And Molecular Sieves (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US80470097A | 1997-02-21 | 1997-02-21 | |
US82531497A | 1997-03-28 | 1997-03-28 | |
US08/943,576 US6080787A (en) | 1997-02-21 | 1997-10-03 | Methods for reducing the incidence of necrotizing enterocolitis |
PCT/US1998/003235 WO1998036745A2 (en) | 1997-02-21 | 1998-02-19 | Use of polyunsaturated fatty acids for reducing the incidence of necrotizing enterocolitis |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0300236A2 HUP0300236A2 (hu) | 2003-06-28 |
HUP0300236A3 true HUP0300236A3 (en) | 2003-09-29 |
Family
ID=27420004
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0300236A HUP0300236A3 (en) | 1997-02-21 | 1998-02-19 | Use of polyunsaturated fatty acids for reducing the incidence of necrotizing enterocolitis and process for their preparation |
Country Status (24)
Country | Link |
---|---|
US (1) | US6306908B1 (hu) |
EP (1) | EP1039892B1 (hu) |
JP (1) | JP2001516343A (hu) |
CN (1) | CN1200701C (hu) |
AT (1) | ATE265207T1 (hu) |
AU (1) | AU732903B2 (hu) |
BR (1) | BR9807443A (hu) |
CA (1) | CA2281706C (hu) |
DE (1) | DE69823548T2 (hu) |
DK (1) | DK1039892T3 (hu) |
ES (1) | ES2219871T3 (hu) |
HK (1) | HK1034033A1 (hu) |
HU (1) | HUP0300236A3 (hu) |
ID (1) | ID22744A (hu) |
IL (1) | IL131126A (hu) |
NO (1) | NO994052L (hu) |
NZ (1) | NZ337039A (hu) |
PL (1) | PL343902A1 (hu) |
PT (1) | PT1039892E (hu) |
RU (1) | RU2199317C2 (hu) |
SK (1) | SK112399A3 (hu) |
TR (1) | TR199902023T2 (hu) |
TW (1) | TWI230607B (hu) |
WO (1) | WO1998036745A2 (hu) |
Families Citing this family (106)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL121165A0 (en) * | 1997-06-26 | 1997-11-20 | Yissum Res Dev Co | Pharmaceutical compositions containing carboxylic acids and derivatives thereof |
US6180671B1 (en) * | 1998-03-10 | 2001-01-30 | Beth Israel Deaconess Medical Center, Inc. | Methods for treating disorders in which docosahexaenoic acid (DHA) levels are affected |
DE19836339B4 (de) | 1998-08-11 | 2011-12-22 | N.V. Nutricia | Kohlenhydratmischung |
US20090274660A1 (en) * | 1999-08-17 | 2009-11-05 | Immunopath Profile, Inc. | Pluripotent therapeutic compositions and uses thereof |
US6596302B2 (en) * | 2000-04-13 | 2003-07-22 | Abbott Laboratories | Infant formulas containing long-chain polyunsaturated fatty acids and uses thereof |
ES2424989T3 (es) * | 2002-09-24 | 2013-10-10 | Suntory Holdings Limited | Composición que contiene ácido araquidónico solo o en combinación con ácido docosahexaenoico para potenciar las capacidades cognitivas en adultos |
US7323206B1 (en) | 2003-03-04 | 2008-01-29 | B. Braun Medical Inc. | Reagents and methods for all-in-one total parenteral nutrition for neonates and infants |
GB0311081D0 (en) * | 2003-05-14 | 2003-06-18 | Btg Internat Limted | Treatment of neurodegenerative conditions |
CA2532489C (en) * | 2003-06-23 | 2012-12-11 | Nestec S.A. | Infant or follow-on formula |
MXPA05014190A (es) * | 2003-06-24 | 2006-07-03 | Univ Kansas Medical Center | Formula para lactantes. |
EP1660071A1 (en) * | 2003-08-18 | 2006-05-31 | Btg International Limited | Treatment of neurodegenerative conditions |
EP1597978A1 (en) | 2004-05-17 | 2005-11-23 | Nutricia N.V. | Synergism of GOS and polyfructose |
US8252769B2 (en) * | 2004-06-22 | 2012-08-28 | N. V. Nutricia | Intestinal barrier integrity |
EP1721611A1 (en) * | 2005-04-21 | 2006-11-15 | N.V. Nutricia | Nutritional supplement with oligosaccharides for a category of HIV patients |
RU2429718C2 (ru) * | 2004-06-22 | 2011-09-27 | Н.В. Нютрисиа | Повышение целостности барьера у больных с вич |
US7862808B2 (en) | 2004-07-01 | 2011-01-04 | Mead Johnson Nutrition Company | Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12 |
EP1656839A1 (en) * | 2004-11-11 | 2006-05-17 | N.V. Nutricia | Nutrition containing lipid blend |
GB0425932D0 (en) * | 2004-11-25 | 2004-12-29 | Btg Int Ltd | Structured phospholipids |
GB0504362D0 (en) * | 2005-03-02 | 2005-04-06 | Btg Int Ltd | Cytokine modulators |
GB0504333D0 (en) * | 2005-03-02 | 2005-04-06 | Btg Int Ltd | Treatment of cytokine dysregulation |
US7303745B2 (en) | 2005-04-15 | 2007-12-04 | Bristol-Myers Squibb Company | Method for preventing or treating the development of respiratory allergies |
US20060233762A1 (en) * | 2005-04-15 | 2006-10-19 | Mcmahon Robert J | Method for treating or preventing systemic inflammation in formula-fed infants |
MX2007013075A (es) * | 2005-04-21 | 2008-01-11 | Nutricia Nv | Suplemento nutritivo para pacientes con vih. |
BRPI0613274A2 (pt) | 2005-05-23 | 2009-08-04 | Massachusetts Inst Technology | composições que contêm pufa e métodos de uso das mesmas |
JP2007063219A (ja) * | 2005-09-01 | 2007-03-15 | Juntendo | 新生児壊死性腸炎疾患予防剤 |
US20070166354A1 (en) | 2005-10-26 | 2007-07-19 | Bridget Barrett-Reis | Method of reducing the risk of retinopathy of prematurity in preterm infants |
US7829126B2 (en) | 2005-10-26 | 2010-11-09 | Abbott Laboratories | Infant formulas containing docosahexaenoic acid and lutein |
WO2007059431A1 (en) | 2005-11-14 | 2007-05-24 | The Trustees Of Columbia University In The City Of New York | Use of an omega-3 lipid-based emulsion following ischemic injury to provide protection and recovery in human organs |
AU2006327995B2 (en) * | 2005-12-23 | 2012-09-13 | N.V. Nutricia | Infant nutritional compositions for preventing obesity |
US20080003329A1 (en) * | 2006-06-30 | 2008-01-03 | Ricardo Rueda | Enriched infant formulas |
US20080003330A1 (en) * | 2006-06-30 | 2008-01-03 | Ricardo Rueda | Infant formulas for early brain development |
US7867542B2 (en) * | 2006-11-02 | 2011-01-11 | Ach Food Companies, Inc. | Non-flammable release composition |
EP2200443B2 (en) | 2007-09-17 | 2021-06-30 | Cornell University | Branched chain fatty acids for prevention or treatment of gastrointestinal disorders |
CN101896073B (zh) * | 2007-10-09 | 2013-11-20 | 酶学技术有限公司 | 用于治疗胃肠道紊乱和促进肠道发育及成熟的脂质组合物 |
UY31410A1 (es) * | 2007-10-30 | 2009-05-29 | Composicion que comprende acidos grasos poliinsaturados y carbon vegetal activado | |
CN101909467B (zh) | 2007-11-01 | 2013-04-24 | 恩兹默泰克有限公司 | 用于婴儿营养的脂质混合物 |
US8361534B2 (en) * | 2007-12-20 | 2013-01-29 | Abbott Laboratories | Stable nutritional powder |
AU2008343689A1 (en) * | 2007-12-20 | 2009-07-09 | Abbott Laboratories | Stable nutritional powder |
EP2100897A1 (en) | 2008-01-30 | 2009-09-16 | BNLfood Investments SARL | Lecithin based composition and its use in food |
WO2009096772A1 (en) * | 2008-02-01 | 2009-08-06 | N.V. Nutricia | Composition for stimulating natural killer cell activity |
US9737213B1 (en) * | 2009-03-24 | 2017-08-22 | Vioptix, Inc. | Using an oximeter probe to detect intestinal ischemia |
CN102368913A (zh) * | 2009-04-01 | 2012-03-07 | 雀巢产品技术援助有限公司 | 降低肥胖的风险 |
TW201112967A (en) | 2009-09-16 | 2011-04-16 | Abbott Lab | Dryblended nutritional powders |
TW201121431A (en) | 2009-12-01 | 2011-07-01 | Abbott Lab | Soy protein-based nutritional formula with superior stability |
TWI492744B (zh) * | 2009-12-04 | 2015-07-21 | Abbott Lab | 使用類胡蘿蔔素調節早產兒發炎症之方法 |
CN102665428A (zh) * | 2009-12-08 | 2012-09-12 | 雀巢产品技术援助有限公司 | 含有益生菌和乳脂肪球膜组分的婴儿配方 |
ES2569241T5 (es) | 2010-01-19 | 2019-09-11 | Abbott Lab | Una composición que comprende Lactobacillus rhamnosus HN001 y prebióticos para su uso en el tratamiento de la enfermedad pulmonar alérgica |
CA2785523A1 (en) | 2010-01-29 | 2011-08-04 | Abbott Laboratories | Aseptically packaged nutritional liquids comprising hmb |
US9693577B2 (en) | 2010-01-29 | 2017-07-04 | Abbott Laboratories | Method of preparing a nutritional powder comprising spray dried HMB |
CN102711524B (zh) | 2010-01-29 | 2014-09-10 | 雅培制药有限公司 | 包含hmb钙的营养乳剂 |
TWI526161B (zh) | 2010-06-10 | 2016-03-21 | 亞培公司 | 包含鈣hmb及可溶性蛋白質之實質上透明營養液 |
EP2397038A1 (en) | 2010-06-21 | 2011-12-21 | Abbott Laboratories | Early programming of brain function through soy protein feeding |
WO2012009426A1 (en) | 2010-07-13 | 2012-01-19 | Abbott Laboratories | High tolerance infant formula including hydrolyzed protein |
EP2422629A1 (en) | 2010-08-23 | 2012-02-29 | Abbott Laboratories | Methods for enhancing cognition and/or memory using maltodextrins |
WO2012027287A1 (en) | 2010-08-24 | 2012-03-01 | Abbott Laboratories | Nutritional products including pea protein hydrolysates |
DK2608681T3 (en) | 2010-08-24 | 2015-10-19 | Abbott Lab | Nutritional products with improved organoleptic properties |
ES2558112T3 (es) | 2010-12-29 | 2016-02-02 | Abbott Laboratories | Productos nutricionales que incluyen un nuevo sistema lipídico que incluye monoglicéridos |
US9539269B2 (en) | 2010-12-31 | 2017-01-10 | Abbott Laboratories | Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides |
ES2667393T3 (es) | 2010-12-31 | 2018-05-10 | Abbott Laboratories | Oligosacáridos de leche humana para modular inflamación |
SG191394A1 (en) | 2010-12-31 | 2013-08-30 | Abbott Lab | Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents |
SG191393A1 (en) | 2010-12-31 | 2013-08-30 | Abbott Lab | Neutral human milk oligosaccharides to promote growth of beneficial bacteria |
CN108420076A (zh) * | 2010-12-31 | 2018-08-21 | 雅培制药有限公司 | 包含人乳低聚糖和长链多不饱和脂肪酸的营养型制剂以及其用途 |
BR112013016914A2 (pt) | 2010-12-31 | 2019-09-24 | Abbott Lab | combinação simbiótica de probióticos e oligossacarídeos do leite humano para promover o crescimento de microbiota benéfica |
EP2658399B2 (en) | 2010-12-31 | 2024-02-28 | Abbott Laboratories | Nutritional compositions comprising human milk oligosaccharides for use in treating and/or preventing enteric rotavirus infection |
ES2708924T3 (es) | 2010-12-31 | 2019-04-12 | Abbott Lab | Procedimientos de uso de oligosacáridos de la leche humana para mejorar la salud respiratoria de las vías respiratorias |
WO2013012989A2 (en) | 2011-07-19 | 2013-01-24 | The Trustees Of Columbia University In The City Of New York | Method and system for production of hydrogen and carbon monoxide |
ES2657744T3 (es) | 2011-07-22 | 2018-03-06 | Abbott Laboratories | Galactoligosacáridos para prevenir lesiones y/o promover la curación del tracto gastrointestinal |
EP2750523A1 (en) | 2011-08-29 | 2014-07-09 | Abbott Laboratories | Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract |
BR112014016310A8 (pt) | 2011-12-29 | 2017-07-04 | Abbott Lab | métodos para reduzir a contaminação microbiana de composições nutricionais em pó produzidas por mistura a seco |
WO2013101516A1 (en) | 2011-12-29 | 2013-07-04 | Abbott Laboratories | Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using extracted genomic dna |
US20150064220A1 (en) | 2012-03-27 | 2015-03-05 | Abbott Laboratories | Methods for modulating cell-mediated immunity using human milk oligosaccharides |
WO2013170189A1 (en) | 2012-05-11 | 2013-11-14 | Abbott Laboratories | Combination of beta - hydroxy - beta - methylbutyrate and beta - alanine for increasing muscle blood flow |
ES2572831T3 (es) | 2012-09-14 | 2016-06-02 | Abbott Laboratories | Composiciones nutricionales para su uso en métodos para modular los niveles de corticosterona en individuos con estrés psicológico |
ES2795665T3 (es) | 2012-09-14 | 2020-11-24 | Abbott Lab | Procedimientos para aumentar la funcionalidad cerebral utilizando 2-fucosil-lactosa |
EP2708146A1 (en) | 2012-09-17 | 2014-03-19 | Abbott Laboratories, Inc. | Nutritional composition for pregnant women with a beneficial glucose and insulin profile |
WO2014078544A1 (en) | 2012-11-14 | 2014-05-22 | Abbott Laboratories | Compositions and methods for improving the long term safety of powdered infant formulas |
WO2014099904A1 (en) | 2012-12-17 | 2014-06-26 | Abbott Laboratories | Methods for enhancing motor function, enhancing functional status and mitigating muscle weakness in a subject |
EP2934189B1 (en) | 2012-12-18 | 2019-11-06 | Abbott Laboratories | Human milk oligosaccharides to ameliorate symptoms of stress |
EP2745705A1 (en) | 2012-12-18 | 2014-06-25 | Abbott Laboratories | Nutritional use of human milk oligosaccharides |
WO2014100022A1 (en) | 2012-12-18 | 2014-06-26 | Abbott Laboratories | Dietary oligosaccharides to enhance learning and memory |
CA2894897C (en) | 2012-12-20 | 2018-09-18 | Abbott Laboratories | Nutritional formulations using human milk oligosaccharides for modulating inflammation |
EP2745708A1 (en) | 2012-12-24 | 2014-06-25 | Abbott Laboratories, Inc. | Antidepressant effect of ß-hydroxy-ß-methylbutyrate |
SG11201507198PA (en) | 2013-03-12 | 2015-10-29 | Abbott Lab | Composition comprising a multifunctional viscosity modifying agent |
JP2016517438A (ja) | 2013-03-15 | 2016-06-16 | アボット・ラボラトリーズAbbott Laboratories | 筋肉機能を維持し、改善する方法 |
EP2986163B1 (en) | 2013-03-15 | 2017-04-19 | Abbott Laboratories | Nutritional compositions including calcium beta-hydroxy-beta-methylbutyrate, casein phosphopeptide, and protein |
CN105263321B (zh) | 2013-03-28 | 2018-07-27 | 哥伦比亚大学纽约管理委员会 | 用omega-3甘油酯再灌注促进对用于移植的供体器官的保护 |
WO2014200961A1 (en) | 2013-06-10 | 2014-12-18 | Abbott Laboratories | Methods and compositions for enhancing cognitive performance |
WO2015048646A1 (en) | 2013-09-30 | 2015-04-02 | Abbott Laboratories | Protein powder |
CA2889312A1 (en) | 2013-10-11 | 2015-04-16 | Normanella Dewille | Nutritional composition for pregnant women with a beneficial glucose and insulin profile |
CN103558296B (zh) * | 2013-10-18 | 2015-03-04 | 中国农业大学 | 一种基于脂肪酸检测的动物源性饲料原料鉴别方法 |
CN104623637A (zh) | 2013-11-07 | 2015-05-20 | 健能隆医药技术(上海)有限公司 | Il-22二聚体在制备静脉注射药物中的应用 |
US10568896B2 (en) | 2013-11-19 | 2020-02-25 | Abbott Laboratories | Methods for preventing or mitigating acute allergic responses using human milk oligosaccharides |
EP2888950A1 (en) | 2013-12-24 | 2015-07-01 | Abbott Laboratories | Methods for treating, preventing, or reducing neuroinflammation or cognitive impairment |
WO2015105981A2 (en) | 2014-01-09 | 2015-07-16 | Abbott Laboratories | Conditional essentiality of hmb |
SG11201608248YA (en) | 2014-04-08 | 2016-10-28 | Abbott Lab | Methods for enhancing mucosal innate immune responses to and/or detection of pathogens using human milk oligosaccharides |
DE102015101273A1 (de) | 2015-01-29 | 2016-08-04 | Eberhard Karls Universität Tübingen Medizinische Fakultät | Prophylaxe und Behandlung von frühgeburtlichkeitsassoziierten Entwicklungsstörungen |
US11510966B2 (en) | 2016-04-15 | 2022-11-29 | Evive Biotechnology (Shanghai) Ltd | Use of IL-22 in treating necrotizing enterocolitis |
RU2665947C1 (ru) * | 2017-07-13 | 2018-09-05 | Атикат Магомедхановна Герейханова | Способ лечения некротического энтероколита |
JP7302032B2 (ja) | 2019-06-07 | 2023-07-03 | アボット・ラボラトリーズ | 流動特性および消泡特性を有する栄養成分 |
MX2022012509A (es) | 2020-04-06 | 2022-11-07 | Abbott Lab | Formulaciones nutricionales para modular citocinas inducidas por la respiracion. |
CN112137998A (zh) * | 2020-10-10 | 2020-12-29 | 上海交通大学医学院附属新华医院 | 一种活性成分在制备防治坏死性小肠结肠炎药物中的应用 |
WO2022177965A1 (en) | 2021-02-16 | 2022-08-25 | Abbott Laboratories | Nutritional compositions comprising human milk oligosaccharides and bovine immunoglobulin |
WO2022226311A1 (en) | 2021-04-23 | 2022-10-27 | Abbott Laboratories | Nutritional compositions comprising human milk oligosaccharides and a designed lipid component for improving lung function |
WO2022266058A1 (en) | 2021-06-14 | 2022-12-22 | Abbott Laboratories | Methods and compositions for treating gas |
WO2023159093A1 (en) | 2022-02-16 | 2023-08-24 | Abbott Laboratories | Nutritional compositions comprising human milk oligosaccharides and bovine immunoglobulin |
WO2024064327A1 (en) | 2022-09-22 | 2024-03-28 | Abbott Laboratories | Human milk oligosaccharides for enhancing blood-brain barrier function |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0092121B1 (en) | 1982-04-12 | 1987-12-16 | Board Of Regents, The University Of Texas System | Methods and compositions for treating gastro-intestinal ulcer diesease |
US4670285A (en) | 1982-08-06 | 1987-06-02 | The University Of Toronto Innovations Foundation | Infant formula |
US4784861A (en) | 1986-11-24 | 1988-11-15 | Cca Industries, Inc. | Weight-control formulation |
US4950656A (en) | 1987-02-17 | 1990-08-21 | Board Of Regents, The University Of Texas System | Methods and compositions employing unique mixtures of polar and neutral lipids for protecting the gastrointestinal tract |
US4918063A (en) * | 1987-02-17 | 1990-04-17 | Board Of Regents, The University Of Texas System | Methods and compositions employing unique mixtures of polar and neutral lipids for protecting the gastrointestinal tract |
US5043329A (en) | 1987-02-17 | 1991-08-27 | Board Of Regents, University Of Texas System | Methods and compositions employing unique mixtures of polar and neutral lipids for protecting the gastrointestinal tract |
US5032585A (en) | 1987-02-17 | 1991-07-16 | Board Of Regents, The University Of Texas System | Methods and compositions employing unique mixtures of polar and neutral lipids for surfactant replacement therapy |
US5000975A (en) | 1988-12-29 | 1991-03-19 | American Home Products Corporation | Randomized palm oil fat composition for infant formulas |
US5116819A (en) * | 1989-05-05 | 1992-05-26 | Clintec Nutrition Co. | Enteral diet for patients with pulmonary disease |
EP1092352A3 (en) | 1991-01-24 | 2003-08-27 | Martek Corporation | Microbial oil mixtures and uses thereof |
US5658767A (en) | 1991-01-24 | 1997-08-19 | Martek Corporation | Arachidonic acid and methods for the production and use thereof |
WO1993020717A2 (en) * | 1992-04-13 | 1993-10-28 | Research Corporation Technologies, Inc. | Reducing gastrointestinal irritation in infant nutrition |
DE4407939A1 (de) * | 1993-03-15 | 1994-09-22 | Sueddeutsche Kalkstickstoff | Verfahren zur Herstellung von fett- und cholesterinreduzierten pulverförmigen Produkten auf Eibasis |
FR2721481B1 (fr) * | 1994-06-27 | 1996-09-06 | Inst Rech Biolog Sa | Nouvelles compositions diététiques à base de phospholipides et leur utilisation comme complément nutritionnel. |
WO1996010922A1 (de) | 1994-10-05 | 1996-04-18 | Milupa Aktiengesellschaft | Phospholipidhaltige fettmischung mit lcp-fettsäuren |
JPH09201A (ja) * | 1995-06-23 | 1997-01-07 | Akikuni Yakida | 炎症性腸疾患用食品 |
US5917068A (en) | 1995-12-29 | 1999-06-29 | Eastman Chemical Company | Polyunsaturated fatty acid and fatty acid ester mixtures free of sterols and phosphorus compounds |
US5790138A (en) | 1996-01-16 | 1998-08-04 | Monolithic System Technology, Inc. | Method and structure for improving display data bandwidth in a unified memory architecture system |
-
1998
- 1998-02-19 SK SK1123-99A patent/SK112399A3/sk unknown
- 1998-02-19 AU AU61769/98A patent/AU732903B2/en not_active Ceased
- 1998-02-19 EP EP98906580A patent/EP1039892B1/en not_active Revoked
- 1998-02-19 BR BR9807443-1A patent/BR9807443A/pt not_active IP Right Cessation
- 1998-02-19 NZ NZ337039A patent/NZ337039A/en unknown
- 1998-02-19 HU HU0300236A patent/HUP0300236A3/hu unknown
- 1998-02-19 AT AT98906580T patent/ATE265207T1/de not_active IP Right Cessation
- 1998-02-19 PL PL98343902A patent/PL343902A1/xx unknown
- 1998-02-19 ES ES98906580T patent/ES2219871T3/es not_active Expired - Lifetime
- 1998-02-19 PT PT98906580T patent/PT1039892E/pt unknown
- 1998-02-19 DE DE69823548T patent/DE69823548T2/de not_active Revoked
- 1998-02-19 WO PCT/US1998/003235 patent/WO1998036745A2/en active Search and Examination
- 1998-02-19 ID IDW990897A patent/ID22744A/id unknown
- 1998-02-19 RU RU99119892/14A patent/RU2199317C2/ru not_active IP Right Cessation
- 1998-02-19 DK DK98906580T patent/DK1039892T3/da active
- 1998-02-19 CN CNB988043726A patent/CN1200701C/zh not_active Expired - Fee Related
- 1998-02-19 JP JP53687198A patent/JP2001516343A/ja active Pending
- 1998-02-19 CA CA002281706A patent/CA2281706C/en not_active Expired - Fee Related
- 1998-02-19 IL IL13112698A patent/IL131126A/xx not_active IP Right Cessation
- 1998-02-19 TR TR1999/02023T patent/TR199902023T2/xx unknown
- 1998-04-03 TW TW087102492A patent/TWI230607B/zh not_active IP Right Cessation
-
1999
- 1999-08-23 NO NO994052A patent/NO994052L/no not_active Application Discontinuation
-
2000
- 2000-05-12 US US09/570,299 patent/US6306908B1/en not_active Expired - Lifetime
-
2001
- 2001-03-29 HK HK01102292A patent/HK1034033A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
PT1039892E (pt) | 2004-09-30 |
IL131126A (en) | 2003-04-10 |
DK1039892T3 (da) | 2004-08-30 |
JP2001516343A (ja) | 2001-09-25 |
NO994052D0 (no) | 1999-08-23 |
RU2199317C2 (ru) | 2003-02-27 |
TR199902023T2 (xx) | 2001-09-21 |
CA2281706A1 (en) | 1998-08-27 |
CN1269718A (zh) | 2000-10-11 |
DE69823548D1 (de) | 2004-06-03 |
WO1998036745A3 (en) | 2002-10-03 |
WO1998036745A2 (en) | 1998-08-27 |
ID22744A (id) | 1999-12-09 |
EP1039892A2 (en) | 2000-10-04 |
DE69823548T2 (de) | 2005-02-24 |
US6306908B1 (en) | 2001-10-23 |
ES2219871T3 (es) | 2004-12-01 |
HUP0300236A2 (hu) | 2003-06-28 |
BR9807443A (pt) | 2000-04-25 |
AU6176998A (en) | 1998-09-09 |
SK112399A3 (en) | 2000-12-11 |
TWI230607B (en) | 2005-04-11 |
IL131126A0 (en) | 2001-01-28 |
NZ337039A (en) | 2001-06-29 |
ATE265207T1 (de) | 2004-05-15 |
EP1039892B1 (en) | 2004-04-28 |
HK1034033A1 (en) | 2001-10-12 |
AU732903B2 (en) | 2001-05-03 |
CA2281706C (en) | 2008-08-05 |
PL343902A1 (en) | 2001-09-10 |
NO994052L (no) | 1999-10-20 |
CN1200701C (zh) | 2005-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0300236A3 (en) | Use of polyunsaturated fatty acids for reducing the incidence of necrotizing enterocolitis and process for their preparation | |
EP0736545A3 (en) | Ester of dextrin and fatty acids and its use | |
HUP9903703A3 (en) | Process for preparing docosahexaenoic acid and docosapentaenoic acid | |
SG65631A1 (en) | Preparation of acrylic acid and esters | |
IL117251A (en) | Enzymatic process for obtaining polyunsaturated fatty acid triglyceride concentrates | |
AU2738497A (en) | Omega-3 fatty acids and omega-3 phosphatidylcholine in the treatment of bipolar disorder | |
EP1025842A4 (en) | PREPARATION OF A CAPSULE CONTAINING AN UNSATURATED FATTY ACID OR A DERIVATIVE THEREOF, AND METHOD OF MANUFACTURE | |
GB9301629D0 (en) | Formulations containing unsaturated fatty acids | |
PL331700A1 (en) | Method of obtaining fatty acid esters | |
AU4564399A (en) | Polyunsaturated fatty acids in plants | |
ZA9711159B (en) | Immobilized enzyme and its use for the processing of triglyceride oils | |
PL331495A1 (en) | Method of obtaining surface-acting sorbitane esters and fatty acids | |
AU4130597A (en) | Use of essential fatty acids for the treatment and prevention of radiation damage to erythrocytes | |
GB9620248D0 (en) | Esters of unsaturated fatty acids | |
AUPQ480399A0 (en) | Unsaturated fatty acids and their uses in therapy | |
AU3776595A (en) | Process for the hydrolysis of the triglycerides of polyunsaturated fatty acids | |
PL332853A1 (en) | Method of obtaining alpha-alkoxy-alpha-trifluoromethyl-acrylacetic esters and acids | |
SI1039892T1 (en) | Use of polyunsaturated fatty acids for reducing the incidence of necrotizing enterocolitis | |
ZA895758B (en) | Polyunsaturated fatty acids | |
SG65781A1 (en) | Process for the preparation of heteroarylcarboxylic amides and esters | |
IL116134A0 (en) | Iminooxybenzylcrotonate esters their preparation and their use | |
GB9621293D0 (en) | Formulations containing unsaturated fatty acids | |
IL123421A0 (en) | Phenylacetic acids their preparation and compositions comprising them | |
AU3645195A (en) | Modified polyunsaturated fatty acids | |
ZA981668B (en) | Presentation of fatty acids |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD9A | Lapse of provisional protection due to non-payment of fees |